Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation
- PMID: 1235
Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation
Abstract
Cytochrome P-450 was assayed in rat liver homogenates and microsomes in order to calculate microsomal recoveries and correct for losses during ultracentrifugation or sedimentation in presence of CaCl2. The values obtained for corrected microsomal protein in untreated female Sprague-Dawley rats were between 40 and 50 mg/g of liver. The assay of cytochrome P-450 in liver homogenate is accurate enough to calculate a reproducible recovery factor. The value of the method lies in its rapidity, its capacity to correct over a wide range of losses, and its capacity to yield reliable values of the total microsomal protein mass. The limits of this method include overestimation of homogenate cytochrome P-450 and inability to correct for nonmicrosomal protein contamination. Overestimation of cytochrome P-450 can be corrected by measuring the difference in absorbance between 450 and 510 nm with the extinction coefficient of 100 mM-1cm-1. To be accurate, cytochrome P-450 determination on microsomes must be done at protein concentrations of about 3 mg/ml. The error inherent to the method may be kept constant and minimal. The use of correction for microsomal losses is recommended in order to obtain uniformity between results from various laboratories and adequate correlation with in vivo studies of microsomal functions.
Similar articles
-
Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.Drug Metab Dispos. 1985 Jan-Feb;13(1):58-61. Drug Metab Dispos. 1985. PMID: 2858378
-
Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.Cancer Res. 1983 Nov;43(11):5131-7. Cancer Res. 1983. PMID: 6413054
-
Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.Drug Nutr Interact. 1983;2(2):117-30. Drug Nutr Interact. 1983. PMID: 6432511
-
Characterization of a rat lung microsomal fraction obtained by sepharose 2B ultrafiltration.Cancer Res. 1975 Oct;35(10):2820-9. Cancer Res. 1975. PMID: 808269
-
Characterization of human microsomal cytochrome P-450 enzymes.Annu Rev Pharmacol Toxicol. 1989;29:241-64. doi: 10.1146/annurev.pa.29.040189.001325. Annu Rev Pharmacol Toxicol. 1989. PMID: 2658771 Review. No abstract available.
Cited by
-
Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.Clin Pharmacokinet. 2002;41(13):1077-94. doi: 10.2165/00003088-200241130-00005. Clin Pharmacokinet. 2002. PMID: 12403644 Review.
-
Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance.Pharm Res. 2006 Mar;23(3):533-9. doi: 10.1007/s11095-006-9531-2. Epub 2006 Feb 28. Pharm Res. 2006. PMID: 16505976
-
Role of defunctionalized bowel in jejunoileal bypass-induced liver disease in rats.Dig Dis Sci. 1979 Dec;24(12):916-20. doi: 10.1007/BF01311945. Dig Dis Sci. 1979. PMID: 510091
-
Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.J Pharmacokinet Biopharm. 1982 Feb;10(1):53-75. doi: 10.1007/BF01059183. J Pharmacokinet Biopharm. 1982. PMID: 7069578
-
Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):173-183. doi: 10.1007/s13318-020-00666-w. Epub 2020 Dec 19. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33340340